Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (475)
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
333
Price
$5.04
Total Value
$1.68K
Shares Held After
92,464
% of Holdings
0.4%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
37
Price
$5.05
Total Value
$186.85
Shares Held After
92,797
% of Holdings
0.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
251
Price
$5.05
Total Value
$1.27K
Shares Held After
96,136
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
4,170
Price
$13.43
Total Value
$56.01K
Shares Held After
147,712
% of Holdings
2.7%
Altimmune, Inc. (ALT)
GILL JOHN — Director
Shares
9,200
Price
$3.41
Total Value
$31.35K
Shares Held After
21,700
% of Holdings
42.4%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
4,000,000
Price
$1.42
Total Value
$5.68M
Shares Held After
12,000,000
% of Holdings
33.3%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
4,000,000
Price
$1.42
Total Value
$5.68M
Shares Held After
12,000,000
% of Holdings
33.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
8
Price
$325.49
Total Value
$2.60K
Shares Held After
11,729
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
81
Price
$323.64
Total Value
$26.21K
Shares Held After
11,737
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
245
Price
$322.86
Total Value
$79.10K
Shares Held After
11,818
% of Holdings
2.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
224
Price
$321.64
Total Value
$72.05K
Shares Held After
12,063
% of Holdings
1.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
147
Price
$320.62
Total Value
$47.13K
Shares Held After
12,287
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
86
Price
$319.69
Total Value
$27.49K
Shares Held After
12,434
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
209
Price
$318.47
Total Value
$66.56K
Shares Held After
12,520
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
359
Price
$317.44
Total Value
$113.96K
Shares Held After
12,729
% of Holdings
2.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
McLaughlin Melissa — Chief Human Resources Officer
Shares
265
Price
$316.61
Total Value
$83.90K
Shares Held After
13,088
% of Holdings
2.0%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
20,000
Price
$6.09
Total Value
$121.80K
Shares Held After
3,012,000
% of Holdings
0.7%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
799
Price
$4.91
Total Value
$3.92K
Shares Held After
65,466
% of Holdings
1.2%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
1,525
Price
$19.06
Total Value
$29.07K
Shares Held After
5,144,998
% of Holdings
0.0%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
258,475
Price
$18.23
Total Value
$4.71M
Shares Held After
5,146,523
% of Holdings
4.8%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,967
Price
$4.91
Total Value
$29.30K
Shares Held After
613,029
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,879
Price
$4.91
Total Value
$9.23K
Shares Held After
160,087
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,038
Price
$4.91
Total Value
$5.10K
Shares Held After
92,834
% of Holdings
1.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
1,521
Price
$4.91
Total Value
$7.47K
Shares Held After
96,387
% of Holdings
1.6%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
371
Price
$21.36
Total Value
$7.93K
Shares Held After
15,150
% of Holdings
2.4%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
415
Price
$20.52
Total Value
$8.51K
Shares Held After
15,521
% of Holdings
2.6%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
265
Price
$21.36
Total Value
$5.66K
Shares Held After
82,027
% of Holdings
0.3%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
293
Price
$20.51
Total Value
$6.01K
Shares Held After
82,292
% of Holdings
0.4%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
377
Price
$21.36
Total Value
$8.05K
Shares Held After
24,681
% of Holdings
1.5%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
420
Price
$20.52
Total Value
$8.62K
Shares Held After
25,058
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
24,925
Price
$4.81
Total Value
$119.89K
Shares Held After
401,891
% of Holdings
5.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
829
Price
$67.99
Total Value
$56.36K
Shares Held After
79,115
% of Holdings
1.0%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
6,500
Price
$8.01
Total Value
$52.06K
Shares Held After
151,588
% of Holdings
4.1%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
2,940
Price
$34.71
Total Value
$102.05K
Shares Held After
80,277
% of Holdings
3.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Burns James William — Chief Legal Officer
Shares
3,280
Price
$34.71
Total Value
$113.85K
Shares Held After
49,306
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$571.65
Total Value
$68.60K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$569.75
Total Value
$68.37K
Shares Held After
18,996
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$567.95
Total Value
$227.18K
Shares Held After
19,116
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
323
Price
$566.82
Total Value
$183.08K
Shares Held After
19,516
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
742
Price
$565.99
Total Value
$419.97K
Shares Held After
19,839
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,201
Price
$564.82
Total Value
$1.24M
Shares Held After
20,581
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
896
Price
$563.86
Total Value
$505.22K
Shares Held After
22,782
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
555
Price
$563.00
Total Value
$312.46K
Shares Held After
23,678
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
571
Price
$561.75
Total Value
$320.76K
Shares Held After
24,233
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
72
Price
$560.39
Total Value
$40.35K
Shares Held After
24,804
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$559.03
Total Value
$134.17K
Shares Held After
24,876
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
720
Price
$558.11
Total Value
$401.84K
Shares Held After
25,116
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
977
Price
$557.05
Total Value
$544.23K
Shares Held After
25,836
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
844
Price
$556.17
Total Value
$469.41K
Shares Held After
26,813
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
778
Price
$555.22
Total Value
$431.96K
Shares Held After
27,657
% of Holdings
2.7%
Showing 101–150 of 475 transactions (page 3 of 10)